|
|
ST Pharm Co Ltd
KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/28/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization1,876,810 mln
Float12.96 mln
Earnings Date08/07/2025
P / E
20.87
Premium valuation
1-Year Forecast
177,778
Transformational upside
Relative Strength
17
/ 100
Significantly lagging
Key Fundamentals
EPS3,700
P/E20.87
ROE13.28
ROIC9.88
ROA9.66
Interest Cover7.33
EBITDA, mln129,476
EV / EBITDA13.94
EV / EBIT18.87
Revenue, mln386,456
EV / Revenue4.67
Quote Details
Last
77,200
Change
-3200 (-3.98%)
Open
80,400
Volume
357,311
Turnover
27,584,409,600
Average Volume
105,175
Financial Ratios
Pre-Tax Profit Margin22
Current Ratio2.28
Price / Book3.04
Price / Tangible Book3.13
Price / Free Cash Flow24.04
Debt / Equity0.12
Price / Sales4.93
Financial Strength
Altman Z-Score6.8
Piotroski F-Score
8
/ 9
Beneish M-Score-2.82
Price to Intrinsic Value6.19
Price to Lynch Fair Value0.99
Price to Graham Number1.86
1-Year Target Price177,778
Shiller PE Ratio87.25
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-16.81% |
2
/ 100
 |
| 1 Month |
-15.44% |
17
/ 100
 |
| 2 Months |
-37.89% |
3
/ 100
|
| 6 Months |
-43.15% |
21
/ 100
 |
| 1 Year |
-18.65% |
42
/ 100
 |
|
| |
